14th January 2025
Pharmaceutical Excipients
We have released some changes to how Pharmaceutical Excipients content…
Resources for NHS Wales e-Library users
Essential knowledge to help you make the right decision.
MedicinesComplete makes it easy for health and care professionals to access trusted evidence-based guidance to support confident decision making at the point of need.
Use this page for information, training, and guides to help you get the most out of your access to this trusted online platform.
Find out more about the products you have access to
Quick start guides to help you navigate MedicinesComplete quickly and efficiently
Trusted expertise and guidance
MedicinesComplete brings together trusted knowledge products providing medicines information and expert guidance on the safe use and administration of drugs and medicines, in one place.
Evidence-based, independent information
Clear, concise, and actionable guidance
Wide range of trusted information sources
Decision-support tools and calculators
Regularly updated
Curated by leading scientists, experts, and researchers
Intuitive search experience
Minimise research time
Latest knowledge product updates
Our knowledge products are regularly updated online through MedicinesComplete
14th January 2025
Pharmaceutical Excipients
We have released some changes to how Pharmaceutical Excipients content is displayed on MedicinesComplete to improve your user experience. For more information, see our FAQs here: https://www.pharmaceuticalpress.com/pharmaceutical-excipients-faqs/
This update also contains 1 new monograph (inositol).
Click to close
14th January 2025
Dietary Supplements
This update contains revisions to Niacin, Pantothenic acid, Riboflavin, and…
14th January 2025
Dietary Supplements
This update contains revisions to Niacin, Pantothenic acid, Riboflavin, and Vitamin B12.
Click to close
14th January 2025
British National Formulary
This update contains 15 significant changes, 4 dose changes, 4…
14th January 2025
British National Formulary
This update contains 15 significant changes, 4 dose changes, 4 new monographs, 3 new preparations and 3 deleted monographs.
Significant Changes:
Cefotaxime: removal of indication and dose for emergency treatment of suspected bacterial meningitis or meningococcal disease, before urgent transfer to hospital, in patients who cannot be given benzylpenicillin.
Ceftriaxone: update to indications and dosing for pre-hospital treatment of suspected bacterial meningitis and meningococcal disease.
Central nervous system infections, antibacterial therapy: updated guidance on management.
Chloramphenicol: updated monitoring advice.
Dexamethasone: update to dose advice for adjunctive treatment of suspected bacterial meningitis.
Diabetic foot infections, antibacterial therapy: updated guidance on fluoroquinolones.
Gastro-intestinal system infections, antibacterial therapy: updated guidance on fluoroquinolones.
Glatiramer acetate: anaphylactic reactions may occur months to years after treatment initiation [MHRA/CHM advice].
GLP-1 receptor agonists: reminder of the potential side effects and to be aware of the potential for misuse [MHRA/CHM advice] (advice in dulaglutide, exenatide, liraglutide, lixisenatide, semaglutide and tirzepatide; see example in liraglutide).
Mavacamten: pre-treatment screening advice on genetic testing for treating symptomatic obstructive hypertrophic cardiomyopathy.
Medical emergencies in the community: update to antibacterials for suspected bacterial meningitis and meningococcal disease.
Medroxyprogesterone acetate: risk of meningioma and measures to minimise this risk [MHRA/CHM advice].
Respiratory system infections, antibacterial therapy: updated guidance on fluoroquinolones.
Urinary-tract infections: updated guidance on fluoroquinolones.
Urinary-tract infections: updated guidance on treatment of lower urinary-tract infections.
Dose Changes:
Cefotaxime [removal of intramuscular route for severe susceptible infections due to sensitive Gram-positive and Gram-negative bacteria, and meningitis].
Ceftriaxone [removal of intramuscular route for meningitis].
Ceftriaxone [update to indications and dosing for meningitis and meningococcal disease].
Fluconazole [update to indications and dosing].
New Monographs:
Iqirvo® [elafibranor].
Piasky® [crovalimab].
Sogroya® [somapacitan].
Voydeya® [danicopan].
New Preparations: Alutard SQ Bee® [bee venom extract]; Alutard SQ Wasp® [wasp venom extract]; Itulazax 12 SQ-Bet® [tree pollen extract].
Deleted Monographs: Belantamab mafodotin; Crizanlizumab; Voxelotor.
Click to close
14th January 2025
Herbal Medicines
One record has been selectively revised. Pharmacopoeial information has also been updated….
14th January 2025
Herbal Medicines
One record has been selectively revised. Pharmacopoeial information has also been updated.
Selective revision: Ginger.
Minor updates: British Pharmacopoeia, European Pharmacopoeia, and USP-NF information have been globally updated.
Click to close
14th January 2025
BNF for Children
This update contains 13 significant changes, 4 dose changes, 2…
14th January 2025
BNF for Children
This update contains 13 significant changes, 4 dose changes, 2 new monographs, 2 new preparations and 2 deleted monographs.
Significant Changes:
Cefotaxime: removal of indication and dose for emergency treatment of suspected bacterial meningitis or meningococcal disease, before urgent transfer to hospital, in patients who cannot be given benzylpenicillin.
Ceftriaxone: update to indications and dosing for pre-hospital treatment of suspected bacterial meningitis and meningococcal disease.
Central nervous system infections, antibacterial therapy: updated guidance on management.
Chloramphenicol: updated monitoring advice.
Dexamethasone: update to dose advice for adjunctive treatment of suspected bacterial meningitis.
Fever: updated guidance on management.
GLP-1 receptor agonists: reminder of the potential side effects and to be aware of the potential for misuse [MHRA/CHM advice] (advice in dulaglutide, liraglutide and semaglutide; see example in liraglutide).
Medical emergencies in the community: update to antibacterials for suspected bacterial meningitis and meningococcal disease.
Medroxyprogesterone acetate: risk of meningioma and measures to minimise this risk [MHRA/CHM advice].
Neonatal infection, antibacterial therapy: updated guidance on management.
Respiratory system infections, antibacterial therapy: updated guidance on fluoroquinolones.
Urinary-tract infections: updated guidance on fluoroquinolones.
Urinary-tract infections: updated guidance on treatment of lower urinary-tract infections.
Dose Changes:
Cefotaxime [removal of intramuscular route for severe susceptible infections due to sensitive Gram-positive and Gram-negative bacteria, and meningitis].
Ceftriaxone [removal of intramuscular route for meningitis].
Ceftriaxone [update to indications and dosing for meningitis and meningococcal disease].
Fluconazole [update to indications and dosing].
New Monographs:
Piasky® [crovalimab].
Sogroya® [somapacitan].
New Preparations: Alutard SQ Bee® [bee venom extract]; Alutard SQ Wasp® [wasp venom extract].
Deleted Monographs: Crizanlizumab; Voxelotor.
Click to close
14th January 2025
Stockley’s Herbal Medicines Interactions
Pharmacopoeial information has been updated.
14th January 2025
Stockley’s Herbal Medicines Interactions
Pharmacopoeial information has been updated.
Click to close
Get updates by email
Stay updated on the latest new drugs and significant changes to medicines information on MedicinesComplete when you sign up to our monthly newsletter.
MedicinesComplete webinars
For deeper information about essential knowledge products on MedicinesComplete browse our library of on-demand webinars featuring our expert editorial team, or register for our latest live webinar.
PCF discussion board
Facilitates the exchange of information between colleagues on matters relating to drug and symptom control, non-drug and service issues in palliative and hospice care. Register to take part today.
We welcome your feedback
Have a question or feedback?
For support, to provide feedback on our content, suggest ideas for new content, or for any other enquiry please get in touch.
Join our authors and contributors
If you are interested in creating or contributing to our content on MedicinesComplete please use the link below to find out more.
Opens in a new window